欧宝体育app

The center has a pharmaceutical chemistry department, a macromolecular biology department, a pharmacology department, a pharmacy department and a non-clinical department. It is mainly based on its own early discovery and druggability evaluation and screening system, combined with solid pharmaceutical development and expert resources, through investment, shareholding, Various models such as service shareholding and joint entrepreneurship are used to incubate various innovative drug projects and enhance the long-term imagination and value space of Baicheng Pharmaceutical's innovative drug sector in multiple dimensions. At present, the company is involved in the main aspects of innovative drug research and development such as new drug discovery, lead compound optimization, preclinical development, clinical registration application, and phase 1 clinical trials. It has multiple innovative drug projects under development, one of which has entered clinical phase 1 research (obtained the 2020 Project support from Zhejiang Provincial Key R&D Plan).